VIA
DGX icon

Victrix Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Victrix Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Sell
1,210
-100
-8% -$19.6K 0.11% 70
2026
Q1 		$257K Hold
1,310
– – 0.09% 95
2025
Q4 		$227K Hold
1,310
– – 0.09% 97
2025
Q3 		$250K Hold
1,310
– – 0.14% 65
2025
Q2 		$235K Sell
1,310
-65
-5% -$11.3K 0.1% 96
2025
Q1 		$233K Sell
1,375
-225
-14% -$37K 0.12% 91
2024
Q4 		$241K Buy
+1,600
New +$249K 0.17% 62

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Victrix Investment Advisors's DGX Position: Q2 2026 in Review

Victrix Investment Advisors reduced its Quest Diagnostics (DGX) stake by 7.6% in Q2 2026, selling an estimated $19.6K and leaving 1,210 shares worth $256K. The position accounts for 0.11% of the portfolio, ranked #70.

Victrix Investment Advisors first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $257K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Victrix Investment Advisors held 1,210 shares of Quest Diagnostics worth $256K as of Q2 2026.
  • Victrix Investment Advisors sold 100 Quest Diagnostics shares in Q2 2026, an estimated $19.6K.
  • Quest Diagnostics made up 0.11% of Victrix Investment Advisors's portfolio in Q2 2026, its #70 holding.
  • Victrix Investment Advisors first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • Victrix Investment Advisors's Quest Diagnostics position peaked at $257K in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Victrix Investment Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.